index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

LncRNA Dystrophie musculaire de Becker Exon skipping Dystrophy Duchenne muscular dystrophy Myogenesis NNOS Muscular Dystrophy Mdx mouse Cells Allele‐specific silencing therapy Skeletal muscle Cardiomyopathie Dynamin 2 Centronuclear myopathy Energy Metabolism/drug effects Inbred mdx L-Type Immunoglobulin Fc Fragments/pharmacology Dystrophie Musculaire de Duchenne DMD Diseases Multi exon skipping Muscular dystrophy Antisense oligonucleotides Male Cultured Muscles/physiopathology LKB1 MiARN DMO Inbred C57BL Dystrophie Musculaire de Becker BMD Génomique Becker BMD muscular dystrophy Cell Biology Human Umbilical Vein Endothelial Cells Modificateurs de gènes Invivo Gene Expression Regulation/drug effects Liver CD38 Mice Autophagy Metabolism Calcium Channels NAD+ Animals Delivery Mitochondrial fission Muscle development Dystrophin-EGFP Knockout Gene expression Base Sequence Cachexia Cell Line Myotendinous junction Muscle Biology DMD Morphogenesis Homeostasis Activin Receptors Molecular docking Long QT Becker muscular dystrophy BMD Duchenne DMD dystrophy Muscle Gene modifiers Duchenne muscular dystrophy DMD Clinical trials Epigenetics CaVβs Genomic Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS DHPR α1S Muscular Atrophy Calcium Multiresolution modeling Animal/physiopathology Multi resolution modeling Muscle Strength MES Drp1 CaV subunits Ex-vivo Inhibitors Cardiomyopathy Cell homeostasis Molecular Sequence Data LncARN CTNNB1 Long noncoding RNA Hear Hepatocellular carcinoma Dystrophin central domain Humans Dystrophin Becker muscular dystrophy BMD Dystrophine